Medicare Advantage Provider to Pay Up To $98M to Settle False Claims Act Suit
Independent Health allegedly violated the False Claims Act by submitting invalid diagnosis codes to Medicare to inflate payments for its enrollees
Read More
Pennsylvania Rural Transformation Builds on Existing Economic Development Hubs
The Commonwealth also will modernize its statewide health data infrastructure in alignment with the CMS Health Technology Ecosystem
Man and Machine: A New Age for Medicine
By MIKE MAGEE “As machines become more intelligent and can performance more sophisticated functions, a new relationship between human and automation is dawning. This relationship is moving from master-servant to teammates…” NASA Langley Research Center/2019 “DeepSeek’s Breakthrough Sparks National Pride in China,” screamed the Wall Street Journal headline last week. In the age of Trump’s…
Who’s Policing Opioid Settlement Spending? A Crowdsourced Database Might Help
After years of legal battles, state attorneys general won billions of dollars in opioid settlements from drug companies accused of fueling the addiction crisis. They declared victory at press conferences, and some touted the deals during their gubernatorial campaigns. But now that the windfall is being spent, are attorneys general doing enough to ensure it’s…
Unite Us, Instacart Link Care Coordination and Grocery Benefits to Scale Food-as-Medicine
Unite Us and Instacart announced Tuesday that they are partnering to connect healthcare organizations’ care coordination efforts with grocery benefits, with the aim of making food-as-medicine programs easier to launch and operate at scale. The post Unite Us, Instacart Link Care Coordination and Grocery Benefits to Scale Food-as-Medicine appeared first on MedCity News.
BioMarin’s $270M Inozyme Acquisition Brings Drug That Could Become First for a Rare Disease
Inozyme Pharma’s main asset is in pivotal testing in children who have a rare enzyme deficiency that affects bones and blood vessels. BioMarin Pharmaceutical, already well established in enzyme replacement, said it will use its experience and infrastructure to grow the market for this product, potentially for several indications. The post BioMarin’s $270M Inozyme Acquisition…
How long does it take new medical research to be adopted by real-world physicians?
Conventional wisdom holds that it takes 17 years from medical innovation to adoption in the real-world. However, with advances in information technology, perhaps adoption timelines have shortened. A paper by DiCicca et al. (2024) examines how new clinical trial evidence on breech births impact practice patterns. Specifically, they note that: Using the United States Birth…
Healthcare’s Quiet Dependence on the “Possimpible”
By GANESH ASAITHAMBI In an episode of the sitcom How I Met Your Mother (HIMYM), Barney Stinson introduces a fictional word: possimpible. The possimpible combines “possible” and “impossible” and describes the extraordinary achievements by people who refuse to accept conventional limits. In modern healthcare, the possimpible is no longer a joke; it has quietly become…
Chronic myeloid leukemia treatment intolerance imposes additional resource and economic burden on oncology practices in the United States
That is the title of a new paper out last week in Future Oncology with co-authors Kejal Jadhav, Cheryl Warren, Sabiha Quddus, Nadine Zawadzki, Daisy Yang, Andrea Damon, Kathryn Spurrier, Katharine Batt and David Wei. The abstract is below. ObjectiveTyrosine kinase inhibitors (TKIs) have transformed the prognosis of chronic myeloid leukemia (CML) into a manageable…
At ASCO, Merck KGaA Shows How Its Drug Measures Up as Treatment for Rare Type of Tumor
Merck KGaA’s pimicotinib led to statistically significant improvement on multiple measures of its Phase 3 test in tenosynovial giant cell tumor, positioning the drug to potentially compete with medications from Daiichi Sankyo and Ono Pharma. The Phase 3 results were presented during the annual meeting of the American Society of Clinical Oncology. The post At…